CJC-1295 vs Hgh: Comparing the Indexed Record
CJC-1295 and Hgh appear together in search far more often than they appear together in published methodology. That gap is the useful part.
Compound profiles
CJC-1295 in the indexed record
Indexed output for CJC-1295 stands at 33 records, a limited literature, alongside 1 registered studies on ClinicalTrials.gov.
Recent indexed work appears in Am J Sports Med, Growth Horm IGF Res, J Am Acad Orthop Surg Glob Res Rev, spanning 2006–2026.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — J Clin Endocrinol Metab, 2006. PMID: 16352683
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians — Am J Sports Med, 2026. PMID: 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions — Subst Use Misuse, 2016. PMID: 26771670
Hgh in the indexed record
Hgh returns 5,028 indexed records on PubMed, an extensive record, alongside 7,385 registered studies on ClinicalTrials.gov.
Recent indexed work appears in Ann Endocrinol (Paris), Bioconjug Chem, Handb Exp Pharmacol, spanning 1986–2017.
- [hGH and molecular biology] — Ann Endocrinol (Paris), 1986. PMID: 3548571
- Growth hormone — Handb Exp Pharmacol, 2010. PMID: 20020365
- History of growth hormone therapy — Indian J Pediatr, 2012. PMID: 22081428
- Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma — Oncotarget, 2017. PMID: 29262609
How the literature differs
The indexed record is not symmetrical between these two compounds. Hgh carries 4,995 more indexed records than CJC-1295, which means published methodology, characterisation data and replication attempts are more readily located for Hgh. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (1 vs 7,385) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | CJC-1295 | Hgh |
|---|---|---|
| PubMed indexed records | 33 | 5,028 |
| Registered studies (ClinicalTrials.gov) | 1 | 7,385 |
| Literature depth | Emerging | Extensive |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
CJC-1295 and Hgh sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for CJC-1295 describes conditions validated for CJC-1295: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Hgh without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Physical handling notes
Both arrive lyophilised. Standard practice keeps the unopened vial at -20°C, protected from light, and defers reconstitution until the point of use. Solution-phase stability is the limiting factor in most protocols, not powder-phase stability.
Repeated freezing and thawing is the most common avoidable source of degradation.
Selecting between them for a study design
CJC-1295 and Hgh are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (Hgh) generally offers more methodological precedent.
Documentation standards
Identity and purity are separate claims requiring separate methods. A purity percentage quoted without the analytical method behind it, or a certificate with no lot reference, is a documentation gap rather than verification.
Frequently asked questions
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Are CJC-1295 and Hgh the same compound?
No. They are structurally distinct research compounds with separate literature records — 33 indexed records for CJC-1295 and 5,028 for Hgh.
Which of CJC-1295 or Hgh has more published research?
Hgh, with 5,028 indexed PubMed records against 33.
Related references
- CJC-1295 — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.